Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 4, Pages -
Publisher
American Society for Microbiology
Online
2019-02-12
DOI
10.1128/aac.00007-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges
- (2018) S. Swindells et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study
- (2018) R. K. R. Rajoli et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Creation of a long-acting nanoformulated dolutegravir
- (2018) Brady Sillman et al. Nature Communications
- Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
- (2017) Sergey E. Borisov et al. EUROPEAN RESPIRATORY JOURNAL
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
- (2017) David A Margolis et al. LANCET
- Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis
- (2017) Matthew E. Levy et al. PLoS One
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review
- (2016) Anke L. Stuurman et al. BMC INFECTIOUS DISEASES
- Clofazimine has delayed antimicrobial activity againstMycobacterium tuberculosisbothin vitroandin vivo
- (2016) Nicole C. Ammerman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study
- (2016) Ellen H Luecke et al. Journal of the International AIDS Society
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus
- (2015) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- WHO's new End TB Strategy
- (2015) Mukund Uplekar et al. LANCET
- Formulation and pharmacology of long-acting rilpivirine
- (2015) Peter E. Williams et al. Current Opinion in HIV and AIDS
- Formulation and pharmacology of long-acting cabotegravir
- (2015) Christine Trezza et al. Current Opinion in HIV and AIDS
- Treatment of Latent Tuberculosis Infection
- (2014) Helen R. Stagg et al. ANNALS OF INTERNAL MEDICINE
- Novel Regimens Identified in Mice for Treatment of Latent Tuberculosis Infection in Contacts of Patients with Multidrug-Resistant Tuberculosis
- (2014) Jean-Philippe Lanoix et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
- (2013) Eun Ji Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Adherence Challenges and Long-Acting Injectable Antipsychotic Treatment in Patients with Schizophrenia
- (2013) N. Kirk Morton et al. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2011) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
- (2011) Nicolas Veziris et al. PLoS One
- Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
- (2009) Murad Ibrahim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2009) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now